Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation

Immunology and Cell Biology

Volumn 90, Issue 4, 2012, Pages 429-440

  Lenzo, Jason C ^a   Turner, Amanda L ^a   Cook, Andrew D ^a   Vlahos, Ross ^a   Anderson, Gary P ^a   Reynolds, Eric C ^a   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

inflammation; macrophages; monocytes

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DISEASE SEVERITY; EXTRAVASATION; FLOW CYTOMETRY; HOMEOSTASIS; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PNEUMONIA; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEADY STATE;

ANIMALS; CELL COUNT; CELL LINEAGE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HOMEOSTASIS; MACROPHAGES; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; MONOCYTES; PNEUMONIA; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

MURINAE; MUS;

EID: 84859981936     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.58     Document Type: Article

References (78)

1. Hamilton JA, Tak PP. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 2009; 60: 1210-1221.
2. Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 2008; 84: 623-630.
3. Stanley ER, Hansen G, Woodcock J, Metcalf D. Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed Proc 1975; 34: 2272-2278.
4. Metcalf D, Nicola NA. Biochemistry of the CSFs, Vol 1, 1st edn. Cambridge University Press, New York, USA, 1995.
5. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442-444. (Pubitemid 120014957)
6. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994; 120: 1357-1372. (Pubitemid 24175881)
7. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002; 99: 111-120.
8. Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006; 80: 59-65. (Pubitemid 44835526)
9. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006; 18: 39-48. (Pubitemid 43049646)
10. Dai XM, Zong XH, Sylvestre V, Stanley ER. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 2004; 103: 1114-1123. (Pubitemid 38129579)
11. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai XM et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006; 7: 265-273.
12. Nilsson SK, Lieschke GJ, Garcia-Wijnen CC, Williams B, Tzelepis D, Hodgson G et al. Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 1995; 86: 66-72.
13. Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320: 807-811. (Pubitemid 351929632)
14. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994; 91: 5592-5596. (Pubitemid 24174374)
15. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8: 533-544. (Pubitemid 351913679)
16. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82. (Pubitemid 36859902)
17. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, Drevets DA et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172: 4410-4417. (Pubitemid 38375256)
18. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964. (Pubitemid 41746764)
19. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005; 23: 344-346. (Pubitemid 41443435)
20. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-e80.
21. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007; 178: 5245-5252. (Pubitemid 46595309)
22. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
23. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565. (Pubitemid 38437450)
24. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-1069. (Pubitemid 46798150)
25. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317: 666-670. (Pubitemid 47229966)
26. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-692.
27. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 2007; 179: 3488-3494.
28. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009; 113: 3190-3197.
29. MacDonald KP, Palmer JS, Cronau S, Seppanen E, Olver S, Raffelt NC et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010; 116: 3955-3963.
30. Cook AD, Braine EL, Hamilton JA. Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation. J Immunol 2004; 173: 4643-4651. (Pubitemid 39280698)
31. Cook AD, Braine EL, Hamilton JA. The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J Immunol 2003; 171: 4816-4823. (Pubitemid 37310602)
32. Sudo T, Nishikawa S, Ogawa M, Kataoka H, Ohno N, Izawa A et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 1995; 11: 2469-2476. (Pubitemid 26023814)
33. Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Warner JR, Stanley ER. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 1982; 28: 71-81. (Pubitemid 12223309)
34. Bartocci A, Mastrogiannis DS, Migliorati G, Stockert RJ, Wolkoff AW, Stanley ER. Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc Natl Acad Sci USA 1987; 84: 6179-6183.
35. Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP. Granulocyte/macrophagecolony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. J Biol Chem2002; 277: 42808-42814. (Pubitemid 35285656)
36. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 2004; 286: L877-L885. (Pubitemid 38365075)
37. Campbell IK, Rich MJ, Bischof RJ, Dunn AR, Grail D, Hamilton JA. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 1998; 161: 3639-3644.
38. Barth MW, Hendrzak JA, Melnicoff MJ, Morahan PS. Review of the macrophage disappearance reaction. J Leukoc Biol 1995; 57: 361-367.
39. Chan J, Leenen PJ, Bertoncello I, Nishikawa SI, Hamilton JA. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 1998; 92: 1423-1431. (Pubitemid 28369057)
40. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte- differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 1993; 151: 2399-2408. (Pubitemid 23264492)
41. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-1746. (Pubitemid 24286121)
42. Ryan GR, Dai XM, Dominguez MG, Tong W, Chuan F, Chisholm O et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001; 98: 74-84.
43. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 1992; 20: 1004-1010.
44. Wiktor-Jedrzejczak WW, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med 1982; 156: 1516-1527. (Pubitemid 13232211)
45. de Bruijn MF, Slieker WA, van der Loo JC, Voerman JS, van Ewijk W, Leenen PJ. Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 1994; 24: 2279-2284. (Pubitemid 24303066)
46. Qu C, Edwards EW, Tacke F, Angeli V, Llodra J, Sanchez-Schmitz G et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 2004; 200: 1231-1241. (Pubitemid 39552565)
47. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, Randolph GJ. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med 2006; 203: 583-597.
48. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 1997; 89: 1021-1031. (Pubitemid 127678736)
49. Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M et al. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J Exp Med 2011; 208: 1069-1082.
50. Le Meur Y, Tesch GH, Hill PA, Mu W, Foti R, Nikolic-Paterson DJ et al. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol 2002; 72: 530-537.
51. Melnicoff MJ, Horan PK, Breslin EW, Morahan PS. Maintenance of peritoneal macrophages in the steady state. J Leukoc Biol 1988; 44: 367-375.
52. Volkman A. Disparity in origin of mononuclear phagocyte populations. J Reticuloendothel Soc 1976; 19: 249-268.
53. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968; 128: 415-435.
54. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006; 211: 609-618.
55. Hayashi S, Miyamoto A, Yamane T, Kataoka H, Ogawa M, Sugawara S et al. Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol 1997; 170: 241-247. (Pubitemid 27117907)
56. Manthey CL, Johnson DL, Illig CR, Tuman RW, Zhou Z, Baker JF et al. JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. Mol Cancer Ther 2009; 8: 3151-3161.
57. Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci USA 2005; 102: 16078-16083. (Pubitemid 41552870)
58. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008; 117: 1649-1657. (Pubitemid 351482605)
59. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995; 92: 8264-8268.
60. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol 2000; 68: 144-150.
61. Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM et al. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Arthritis Res Ther 2010; 12: R32.
62. Segawa M, Fukada S, Yamamoto Y, Yahagi H, Kanematsu M, Sato M et al. Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp Cell Res 2008; 314: 3232-3244.
63. Burke B, Ahmad R, Staples KJ, Snowden R, Kadioglu A, Frankenberger M et al. Increased TNF expression in CD43++ murine blood monocytes. Immunol Lett 2008; 118: 142-147.
64. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592. (Pubitemid 46393535)
65. Sardis S, Mukherjee A, Olson S, Dokmanovich M, Maher R, Cai C-H et al. Safety, pharmacokinetics, and pharmacodynamics of PD-0360324, a human monoclonal antibody to monocyte/macrophage colony stimulating factor, in healthy volunteers [abstract]. Arthritis Rheum 2009; 60: 408.
66. Basu S, Dunn AR, Marino MW, Savoia H, Hodgson G, Lieschke GJ et al. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 1997; 159: 1412-1417. (Pubitemid 127484120)
67. Bezbradica JS, Gordy LE, Stanic AK, Dragovic S, Hill T, Hawiger J et al. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 2006; 25: 487-497. (Pubitemid 44354212)
68. Plenz G, Eschert H, Beissert S, Arps V, Sindermann JR, Robenek H et al. Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice. FASEB J 2003; 17: 1451-1457. (Pubitemid 36935660)
69. Hercus TR, Thomas D, Guthridge MA, Ekert PG, King-Scott J, Parker MWet al. The GM-CSF receptor: linking its structure to cell signaling and its role in disease. Blood 2009; 114: 1289-1298.
70. Uchida K, Beck DC, Yamamoto T, Berclaz PY, Abe S, Staudt MK et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356: 567-579. (Pubitemid 46220817)
71. Hopper KE. Kinetics of macrophage recruitment and turnover in peritoneal inflammatory exudates induced by Salmonella or thioglycollate broth. J Leukoc Biol 1986; 39: 435-446. (Pubitemid 16106318)
72. Metcalf D, Robb L, Dunn AR, Mifsud S, Di Rago L. Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice. Blood 1996; 88: 3755-3764. (Pubitemid 26383097)
73. Hamilton JA. Colony stimulating factors, cytokines and monocyte-macrophages - some controversies. Immunol Today 1993; 14: 18-24. (Pubitemid 23028246)
74. Hamilton JA. Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 1993; 342: 536-539. (Pubitemid 23259193)
75. Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo J, Hamilton JA. Bone marrow cellderived granulocyte-macrophage colony stimulating factor regulates systemic and local myeloid populations in inflammatory arthritis. Arthritis Rheum 2011 (in press).
76. Sasmono RT, Oceandy D, Pollard JW, TongW, Pavli P,Wainwright BJ et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003; 101: 1155-1163. (Pubitemid 36139391)
77. Drevets DA, Schawang JE, Mandava VK, Dillon MJ, Leenen PJ. Severe Listeria monocytogenes infection induces development of monocytes with distinct phenotypic and functional features. J Immunol 2010; 185: 2432-2441.
78. Vlahos R, Bozinovski S, Chan SP, Ivanov S, Linden A, Hamilton JA et al. Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 2010; 182: 34-40.